Heart rate variability after BRL37344, a beta-3 agonist, in experimental bladder outlet obstruction
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0
Abstract
Introduction: Bladder overactivity symptoms accompany benign prostatic hyperplasia (BPH) syndrome. The autonomic nervous system (ANS) disturbances may be involved in bladder dysfunction. An ameliorating effect on bladder overactivity is being assigned to the currently investigated β-3 adrenoreceptor agonists. However, little is known about the influence of β-3 agonists on ANS activity. The aim of our study was to estimate ANS activity using heart rate variability (HRV) in experimental model of bladder outlet obstruction (BOO), reflecting human BPH.Material/Methods: 30 female rats, divided into control, non-treated BOO (LLBOO), and β-3 agonist (BRL37344) BOO treated (LLBOO+β3 agonist) were studied. BOO was evoked by 5-week long partial proximal urethra ligation. Next, 20-minute resting HRV recordings were performed in each of the studied groups following i.p. administration of the vehicle (LLBOO) or BRL37344 (LLBOO+β3 agonist).Results: LLBOO rats were characterized by diminished NN range, SDNN, and rMSSD in time-domain analysis. Similarly, TP and non-normalized spectral HRV parameters were also decreased. Contrary to these findings, normalized spectral parameters were lower (nLF) and higher (nHF). The animals treated with BRL37344 demonstrated no significant differences in time--domain HRV parameters. In spectral analysis, a decrease in LF and HF, together with a fall in TP, was found. Moreover, both nLF and nHF reached almost the same values in control and β-3 agonist treated rats.Disscussion: Our data indicates that BRL37344 is an agent abolishing the autonomic imbalance in experimental BOO, which may contribute to relieving the symptoms of bladder overactivity in β-3 agonists treated participants.
Authors and Affiliations
Łukasz Dobrek, Agnieszka Baranowska, Piotr J. Thor
Keywords
Related Articles
- EP ID EP67021
- DOI -
- Views 169
- Downloads 0
Rola mikrobioty jelitowej w patofizjologii depresji
Depresja jest powszechnie występującym zaburzeniem psychicznym, według Światowej Organizacji Zdrowia jest częstą przyczyną niepełnosprawności i główną przyczyną samobójczej śmierci. Ryzyko rozwoju depresji jest większe u...
Endocytoza niezależna od klatryny – rola w patomechanizmie chorób i aspekty farmaceutyczne
Endocytoza niezależna od klatryny (CIE) jest procesem pobierania przez komórki różnych cząstek, w tym również drobnoustrojów chorobotwórczych, bez udziału białka opłaszczającego klatryny. Zachodzi w komórkach ssaków i je...
Rola resweratrolu w regulacji metabolizmu komórkowego
Spożywanie wina w umiarkowanych ilościach wiąże się z obniżonym ryzykiem wystąpienia chorób sercowo-naczyniowych i mózgowo-naczyniowych, chorób naczyń obwodowych, a także nowotworów. Zjawisko to określa się mianem „franc...
Cu-GnRH – new gonadoliberin (GnRH) analog
Our research was concentrated about physiological and structural aspects of metal complexes with GnRH, which were synthetized by Professor Henryk Kozłowski from the Uniwersity of Wrocław. We found that copper, nickel, zi...
Mechanisms of action of the anti-VEGF monoclonal antibody bevacizumab on chronic lymphocytic leukemia cells
Introduction: Chronic lymphocytic leukemia (CLL) remains incurable; therefore searching for new therapeutic strategies in this disease is necessary. An important mechanism of tumor development is neoangiogenesis. A poten...